{"groups":[{"description":"Nivolumab 240 mg flat dose IV Q2W + Cabozantinib 40 mg PO QD","id":"FG000","title":"Treatment A"},{"description":"Nivolumab 3 mg/kg IV Q3W (x4 doses) + Cabozantinib 40 mg PO QD + Ipilimumab 1 mg/kg IV Q3W (x4 doses)\n\nThen\n\nNivolumab 240 mg flat dose IV Q2W + Cabozantinib 40 mg PO QD","id":"FG001","title":"Treatment B"},{"description":"Sunitinib 50 mg PO QD for 4 weeks, followed by 2 weeks off, per cycle","id":"FG002","title":"Treatment C"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"62"},{"groupId":"FG001","numSubjects":"13"},{"groupId":"FG002","numSubjects":"84"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"9"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"13"}],"type":"Participant withdrew consent"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"}],"type":"Not reported"},{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"1"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"11"}],"type":"Other reasons"},{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"8"}],"type":"Participants did not start treatment period"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"323"},{"groupId":"FG001","numSubjects":"50"},{"groupId":"FG002","numSubjects":"328"}],"comment":"Started=Randomized","type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"320"},{"groupId":"FG001","numSubjects":"50"},{"groupId":"FG002","numSubjects":"320"}],"comment":"Treated=Started treatment period","type":"Treated"},{"achievements":[{"groupId":"FG000","numSubjects":"242"},{"groupId":"FG001","numSubjects":"34"},{"groupId":"FG002","numSubjects":"210"}],"comment":"Completed=Continuing in the Study","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"81"},{"groupId":"FG001","numSubjects":"16"},{"groupId":"FG002","numSubjects":"118"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"701 participants randomized and 690 treated."}